News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,363 Results
Type
Article (87712)
Company Profile (824)
Press Release (777814)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233160)
Career Advice (4142)
Deals (39828)
Drug Delivery (144)
Drug Development (91341)
Employer Resources (203)
FDA (18342)
Job Trends (17414)
News (397663)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (164)
Alzheimer's disease (1752)
Antibody-drug conjugate (ADC) (300)
Approvals (18426)
Artificial intelligence (570)
Autoimmune disease (127)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (184)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (60)
Breast cancer (576)
Cancer (4569)
Cardiovascular disease (402)
Career advice (3564)
Career pathing (39)
CAR-T (286)
CDC (59)
Cell therapy (773)
Cervical cancer (36)
Clinical research (76391)
Collaboration (1557)
Company closure (5)
Compensation (1047)
Complete response letters (64)
COVID-19 (2973)
CRISPR (93)
C-suite (717)
Cystic fibrosis (146)
Data (5664)
Decentralized trials (2)
Denatured (67)
Depression (129)
Diabetes (489)
Diagnostics (7156)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (220)
Earnings (99867)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134422)
Executive appointments (1008)
FDA (21130)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1412)
Gene editing (200)
Generative AI (58)
Gene therapy (613)
GLP-1 (1077)
Government (5415)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (31)
Indications (71)
Infectious disease (3239)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17941)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (639)
Lymphoma (354)
Machine learning (38)
Management (66)
Manufacturing (725)
MASH (164)
Medical device (14959)
Medtech (14997)
Mergers & acquisitions (22855)
Metabolic disorders (1269)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (314)
Neuropsychiatric disorders (82)
Neuroscience (2926)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (604)
Opinion (324)
Ovarian cancer (151)
Pain (181)
Pancreatic cancer (195)
Parkinson's disease (265)
Partnered (34)
Patents (457)
Patient recruitment (387)
Peanut (58)
People (66581)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23584)
Phase II (33163)
Phase III (24983)
Pipeline (3687)
Policy (317)
Postmarket research (3554)
Preclinical (10650)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (784)
Real estate (7434)
Recruiting (80)
Regulatory (28461)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (22)
RNA editing (16)
RSV (82)
Schizophrenia (146)
Series A (228)
Series B (175)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1095)
Venture capital (76)
Weight loss (424)
Women's health (74)
Worklife (21)
Date
Today (127)
Last 7 days (698)
Last 30 days (2948)
Last 365 days (33443)
2025 (31899)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (51270)
Australia (9010)
California (10678)
Canada (3126)
China (1027)
Colorado (450)
Connecticut (478)
Delaware (320)
Europe (117872)
Florida (1567)
Georgia (344)
Hawaii (3)
Idaho (68)
Illinois (882)
India (62)
Indiana (513)
Iowa (22)
Japan (368)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1392)
Massachusetts (7937)
Michigan (337)
Minnesota (617)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (116)
New Hampshire (81)
New Jersey (2925)
New Mexico (32)
New York (2861)
North Carolina (1521)
North Dakota (10)
Northern California (5012)
Ohio (324)
Oklahoma (22)
Oregon (52)
Pennsylvania (2170)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4104)
Tennessee (164)
Texas (1667)
United States (38912)
Utah (322)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (900)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
There are 866,363 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A
December 9, 2025
·
2 min read
Press Releases
ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of Olverembatinib, Reaffirming Differentiated Long-Term Efficacy and Safety in TKI-Resistant/Intolerant CML-CP
December 9, 2025
·
12 min read
Press Releases
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
December 9, 2025
·
11 min read
Press Releases
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
December 9, 2025
·
11 min read
Press Releases
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
December 9, 2025
·
19 min read
Press Releases
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia
December 9, 2025
·
10 min read
Press Releases
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
December 9, 2025
·
19 min read
Press Releases
Qihan Biotech Presents New Clinical Data on Allogeneic CAR-T Cell Therapies and Preclinical Data on In Vivo CAR-T at the American Society of Hematology (ASH) Annual Meeting
December 9, 2025
·
6 min read
Press Releases
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 9, 2025
·
1 min read
Press Releases
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 9, 2025
·
1 min read
1 of 86,637
Next
